IFNG and fibrosarcoma: In order to confirm our hypothesis that the MAU-AW sub-fraction can increase IFN-γ in the tumor microenvironment, the MAU-AW sub-fraction (10 μg) was administered intra-peritoneally for three successive days into mice bearing MCA fibrosarcoma.